Gary, Many of these putative biotech analysts are intellectually dysfunctioning clones. Their inability to apply deductive reasoning, to analyze data, the FDA and just basic reading comprehension is astounding. How can anybody deduct from the FDA's query requests that the FDA is much less likely to approve AA?? I'm sorry. I just don't get it. There are exceptions. Ren Renjamin and Ed Nash are both quality analysts that I have spoken with and they get it and they both actually know the radical chemical differences between the S-DNA's and the PMO's. Many in biotech do not.
its clear that you only like the opinions that support your own. plus you have no idea who these analysts are or their daily body of work. you may not like the leerink downgrade but at the moment they certainly are on the right side of the trade and believe that the process will take longer than many anticipate for approval, ed nash is a rookie analyst & I guarantee that you know little of his work.